Distinguished in COVID-19

Dr. Todd W. Rice

Intensive Care Medicine | Pulmonary Medicine
3601 The Vanderbilt Clinic, 
Nashville, TN 
Accepting New Patients
Offers Telehealth
Distinguished in COVID-19
3601 The Vanderbilt Clinic, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Todd Rice is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Nashville, Tennessee. Dr. Rice is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cerebral Hypoxia, COVID-19, Severe Acute Respiratory Syndrome (SARS), Endoscopy, and Advanced Bronchoscopy. Dr. Rice is currently accepting new patients.

His clinical research consists of co-authoring 350 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 67 articles and participated in 3 clinical trials in the study of COVID-19.

Specialties
Intensive Care Medicine
Pulmonary Medicine
Licenses
Critical Care Medicine in TN
Hospital Affiliations
Vanderbilt University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alliant Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

VANDERBILT UNIVERSITY MEDICAL CENTER
3601 The Vanderbilt Clinic, Nashville, TN 37232
Other Locations
VANDERBILT UNIVERSITY MEDICAL CENTER
719 Thompson Ln, Nashville, TN 37204
VANDERBILT UNIVERSITY MEDICAL CENTER
2603 Bransford Ave, Nashville, TN 37204
VANDERBILT UNIVERSITY MEDICAL CENTER
2694 Fessey Ct, Nashville, TN 37204
VANDERBILT UNIVERSITY MEDICAL CENTER
2410 8th Ave S, Nashville, TN 37204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Enrollment Status: Completed
Publish Date: December 24, 2024
Intervention Type: Drug
Study Phase: Phase 2
Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19
Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Other, Drug
Study Drug: Lopinavir
Study Phase: Phase 2
Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment
Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Drug: BLD-2660
Study Phase: Phase 2
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial
Enrollment Status: Completed
Publish Date: March 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Enrollment Status: Completed
Publish Date: December 16, 2019
Intervention Type: Other
Study Phase: Not Applicable
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Enrollment Status: Completed
Publish Date: November 25, 2019
Intervention Type: Other
Study Phase: Not Applicable
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Enrollment Status: Completed
Publish Date: September 13, 2018
Intervention Type: Other
Study Phase: Not Applicable
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
Enrollment Status: Completed
Publish Date: January 26, 2018
Intervention Type: Other
Study Phase: Not Applicable
Scanning of Bilateral Internal Jugular Veins With Ultrasound Prior to CVC Placement - Effect on Success and Complications
Scanning of Bilateral Internal Jugular Veins With Ultrasound Prior to CVC Placement - Effect on Success and Complications
Enrollment Status: Completed
Publish Date: July 14, 2017
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

348 Total Publications

Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Similar Doctors
Distinguished in COVID-19
Dr. Jonathan D. Casey
Intensive Care Medicine | Pulmonary Medicine
Distinguished in COVID-19
Dr. Jonathan D. Casey
Intensive Care Medicine | Pulmonary Medicine

Vanderbilt University Medical Center

1301 22nd Ave S, 
Nashville, TN 
 (0.1 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Casey is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Nashville, Tennessee. Dr. Casey is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cerebral Hypoxia, COVID-19, Severe Acute Respiratory Syndrome (SARS), Advanced Bronchoscopy, and Endoscopy. Dr. Casey is currently accepting new patients.

Advanced in COVID-19
Dr. Murray M. Arons
Pulmonary Medicine | Intensive Care Medicine
Advanced in COVID-19
Dr. Murray M. Arons
Pulmonary Medicine | Intensive Care Medicine

Saint Thomas Medical Partners

1800 Medical Ctr Pkwy, Suite 400, 
Murfreesboro, TN 
 (28.5 miles away)
615-284-2015
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Murray Arons is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Murfreesboro, Tennessee. Dr. Arons is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pneumonia, Lung Metastases, Hospital-Acquired Pneumonia, Gastrostomy, and Endoscopy. Dr. Arons is currently accepting new patients.

Advanced in COVID-19
Dr. Robert P. Mildenhall
Pulmonary Medicine
Advanced in COVID-19
Dr. Robert P. Mildenhall
Pulmonary Medicine

Saint Thomas Medical Partners

300 20th Ave N, 
Nashville, TN 
 (1.1 miles away)
615-284-1400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Mildenhall is a Pulmonary Medicine provider in Nashville, Tennessee. Dr. Mildenhall is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Atypical Pneumonia, Hospital-Acquired Pneumonia, COVID-19, Gastrostomy, and Endoscopy. Dr. Mildenhall is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rice's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile